$Rallybio (RLYB.US)$ NEWS Rallybio Announces Collaboration ...
NEWS
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Rallybio partners with Johnson & Johnson to develop therapies for FNAIT, receives $6.6 million investment. RLYB212 aims to prevent FNAIT in pregnant individuals. Phase 2 study planned for 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
602Followers
72Following
3844Visitors
Follow
DarthTrader069 : any investment from J&J and not much movement. I have no faith anymore
Jaguar8OP DarthTrader069: It’s already up 38%
DarthTrader069 Jaguar8OP: true true, figured it would have ran a little more is all.
Jaguar8OP DarthTrader069: Oh it’s AH. Maybe in a little bit when they get to read it